Board Member
Definium Therapeutics, Inc. (DFTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2021-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | $655,000 | $12,767,442 |
| 2024 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | $623,500 | $2,669,010 |
| 2021 | Definium Therapeutics, Inc. (DFTX) | Chief Executive Officer | $350,000 | $11,889,466 |
Earnings-call appearances and filed executive appointments or departures, newest first.
